X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (533) 533
humans (502) 502
female (331) 331
male (323) 323
middle aged (227) 227
adult (217) 217
psychiatry (192) 192
12-month prevalence (169) 169
aged (157) 157
treatment outcome (132) 132
12-month outcomes (116) 116
ophthalmology (114) 114
sustained benefits (105) 105
adolescent (104) 104
12-month follow-up (100) 100
prevalence (100) 100
ranibizumab (91) 91
12-month (89) 89
young adult (89) 89
comorbidity (74) 74
united-states (73) 73
depression (71) 71
phase-iii (69) 69
analysis (68) 68
risk factors (67) 67
article (65) 65
time factors (64) 64
epidemiology (62) 62
follow-up studies (61) 61
care and treatment (60) 60
intravitreal injections (60) 60
aged, 80 and over (58) 58
substance abuse (58) 58
psychiatric-disorders (57) 57
abridged index medicus (55) 55
12-month-old infants (48) 48
clinical neurology (47) 47
psychology (47) 47
vascular endothelial growth factor a - antagonists & inhibitors (47) 47
retinal vein occlusion - drug therapy (46) 46
macular edema - drug therapy (45) 45
research (45) 45
retrospective studies (45) 45
bipolar disorder (44) 44
infants (44) 44
bevacizumab (43) 43
macular edema (43) 43
mental disorders (43) 43
prospective studies (43) 43
psychology, clinical (43) 43
surveys and questionnaires (43) 43
mental health (42) 42
retinal vein occlusion (42) 42
psychology, developmental (41) 41
efficacy (40) 40
anxiety (39) 39
public, environmental & occupational health (39) 39
risk-factors (39) 39
cross-sectional studies (38) 38
studies (38) 38
vascular endothelial growth factor (38) 38
endothelial growth-factor (37) 37
mental disorders - epidemiology (37) 37
psychology, experimental (37) 37
angiogenesis inhibitors - therapeutic use (36) 36
health surveys (36) 36
medical research (36) 36
visual acuity (36) 36
cardiac & cardiovascular systems (35) 35
infant (35) 35
pharmacology & pharmacy (35) 35
clinical trials (34) 34
national-comorbidity-survey (34) 34
surgery (34) 34
therapy (34) 34
alcohol use (33) 33
retinal vein occlusion - complications (32) 32
tomography, optical coherence (32) 32
double-blind (31) 31
patients (31) 31
safety (31) 31
sex factors (31) 31
adults (30) 30
macular edema - etiology (30) 30
substance use disorders (30) 30
anxiety disorders (29) 29
children (29) 29
disorders (29) 29
medicine & public health (29) 29
psychiatric status rating scales (29) 29
age factors (28) 28
branch (28) 28
child development (28) 28
health aspects (28) 28
macular degeneration (28) 28
trial (28) 28
babies (27) 27
drug therapy (27) 27
eye diseases (27) 27
medicine, experimental (27) 27
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Pakistan Journal of Medical Sciences, ISSN 1682-024X, 2015, Volume 31, Issue 3, pp. 510 - 515
Objectives: To evaluate the effects and safety of intravitreal ranibizumab on visual acuity and anatomic results in the treatment of macular edema due to... 
Macular thickness | Retinal Vein Occlusion | Ranibizumab | MEDICINE, GENERAL & INTERNAL | MACULAR EDEMA | LONG-TERM OUTCOMES | PHASE-III | SUSTAINED BENEFITS | ENDOTHELIAL GROWTH-FACTOR | 12-MONTH OUTCOMES | Diabetic retinopathy | Ophthalmology | Original
Journal Article
European Journal of Obstetrics and Gynecology, ISSN 0301-2115, 1986, Volume 23, Issue 3, pp. 211 - 223
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 07/1992, Volume 20, Issue 1, pp. 17 - 23
Clot dissolution with restoration of infarct-related artery blood flow is the likely mechanism for the improved prognosis and mortality reduction seen after... 
SURVIVAL | MULTICENTER | CARDIAC & CARDIOVASCULAR SYSTEMS | ARTERIAL PATENCY | 12-MONTH FOLLOW-UP | INTRAVENOUS STREPTOKINASE | TIMI TRIAL | REPERFUSION THERAPY | PHASE-I | THROMBOLYTIC THERAPY | LEFT-VENTRICULAR FUNCTION
Journal Article
Bailliere's Clinical Gastroenterology, ISSN 0950-3528, 1992, Volume 6, Issue 4, pp. 697 - 714
Journal Article
HERZ, ISSN 0340-9937, 02/1992, Volume 17, Issue 1, pp. 50 - 63
With intravenous thrombolysis mortality of acute myocardial infarction can be significantly reduced, not only in the first hours after the onset of symptoms,... 
INTRACORONARY STREPTOKINASE | SURVIVAL | FIBRILLATION | CARDIAC & CARDIOVASCULAR SYSTEMS | TISSUE PLASMINOGEN-ACTIVATOR | RANDOMIZED CLINICAL-TRIAL | 12-MONTH FOLLOW-UP | INTRAVENOUS STREPTOKINASE | LUMINAL CORONARY ANGIOPLASTY | THROMBOLYTIC THERAPY | LEFT-VENTRICULAR FUNCTION
Journal Article
American Heart Journal, ISSN 0002-8703, 1993, Volume 126, Issue 4, pp. 819 - 826
Coronary artery patency after thrombolytic therapy has important prognostic implications for survival after acute myocardial infarction. The ability to... 
ISOENZYME | ARTERY PATENCY | STREPTOKINASE | CARDIAC & CARDIOVASCULAR SYSTEMS | THERAPY | PLASMINOGEN-ACTIVATOR | ACUTE MYOCARDIAL-INFARCTION | 12-MONTH FOLLOW-UP | TIME | TRANSLUMINAL CORONARY ANGIOPLASTY | RANDOMIZED TRIAL
Journal Article